Multiple research studies have indicated that a significant number of cancer types frequently exhibit elevated levels of BIRC5, which is linked to resistance against chemicals and an unfavorable prognosis in individuals with cancer, such as lung adenocarcinoma [42], neuroblastoma [43], and glioma [44]. This evidence concerns the gene BIRC5 and neuroblastoma.